Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 5.90

From 52W high−33.63%

Volume130.11M

Market capCNY 5.64B

P/E (TTM)80.0x

P/S (TTM)2.4x

Div yield0.85%

Key dataSep 18, 2026

Open

CNY 5.90

From 52W high

−33.63%

Volume

130.11M

Market cap

CNY 5.64B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.4x

P/E (TTM)

80.0x

RSI (14)

58.5

MomentumView details →

1D Return

−6.17%

YTD Return

+49.14%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

80.0x

EV/EBITDA

15.4x

EV/Sales

2.7x

P/S (TTM)

2.4x

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

41.18%

Net Margin

0.97%

EBITDA Margin

17.78%

ROE (TTM)

0.87%

ROA (TTM)

0.47%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

−12.97%

EPS YoY

−79.87%

FCF YoY

−80.96%

Revenue CAGR 3Y

−7.62%

EPS CAGR 3Y

+26.64%

EBITDA YoY

—

MomentumView details →

1D Return

−6.17%

YTD Return

+49.14%

1Y Return

+46.63%

RSI (14)

58.5

vs 50D SMA

+8.36%

vs 200D SMA

+19.79%

Capital & dividendView details →

Debt/Equity

0.21x

Current Ratio

2.08x

Quick Ratio

1.47x

Div Yield

0.85%

Div Rate

CNY 0.05

Div Growth 1Y

−46.94%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.73B

Net Income (TTM)

26.41M

Op. CF (TTM)

135.63M

Latest newsMore news →

Hubei Jinyao, a subsidiary of Jinyao Pharmaceutical, received a drug registration certificate from China's National Medical Products Administration for bupivacaine hydrochloride injection (10ml:75mg), deemed to have passed generic drug consistency evaluation.6d ago

Jinyao Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders was 43.1735 million yuan, down 12.43% year-on-year.26d ago

Similar companies

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.09989.HK 华纳药厂688799.SH 人民同泰600829.SH Amneal Pharmaceuticals, Inc.AMRX 圣诺生物688117.SH China Shineway Pharmaceutical Group Limited02877.HK Find similar companies →

Latest newsMore news →

Hubei Jinyao, a subsidiary of Jinyao Pharmaceutical, received a drug registration certificate from China's National Medical Products Administration for bupivacaine hydrochloride injection (10ml:75mg), deemed to have passed generic drug consistency evaluation.6d ago Jinyao Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders was 43.1735 million yuan, down 12.43% year-on-year.26d ago